Cortese Laura, Pelagalli Alessandra, Piantedosi Diego, Mastellone Vincenzo, Di Loria Antonio, Lombardi Pietro, Ciaramella Paolo, Avallone Luigi
Department of Veterinary Clinical Sciences, University of Naples Federico II, Via Delpino 1, 80137, Italy.
Vet J. 2008 Sep;177(3):405-10. doi: 10.1016/j.tvjl.2007.05.011. Epub 2007 Jul 12.
Thirty dogs naturally infected with Leishmania infantum were studied in order to determine the effects of treatment on haemostatic function. The animals were divided randomly into two treatment groups: Group 1 received meglumine antimoniate and allopurinol; Group 2 dogs were given the same treatment plus prednisone. Ten healthy animals were used as untreated controls. Clinical examination and determination of platelet aggregation, coagulation factors and biochemical parameters were undertaken before treatment and after 15, 30 and 60 days. A significant improvement in platelet aggregation was detected after 60 days in Group 1, but only after 15 days in Group 2. In both treated groups, platelet aggregation was lower than in the control group at the end of the study. The results suggest that prednisone may be a useful tool in the treatment of haemostatic disorders during canine leishmaniosis. The potential benefits and risks due to the use of corticosteroids in the treatment of leishmaniosis are discussed.
为了确定治疗对止血功能的影响,对30只自然感染婴儿利什曼原虫的犬进行了研究。这些动物被随机分为两个治疗组:第1组接受葡甲胺锑酸盐和别嘌呤醇治疗;第2组犬接受相同治疗并加用泼尼松。选取10只健康动物作为未治疗对照。在治疗前以及治疗15天、30天和60天后进行临床检查,并测定血小板聚集、凝血因子和生化参数。第1组在60天后检测到血小板聚集有显著改善,但第2组仅在15天后有改善。在研究结束时,两个治疗组的血小板聚集均低于对照组。结果表明,泼尼松可能是治疗犬利什曼病期间止血障碍的一种有用药物。文中讨论了使用皮质类固醇治疗利什曼病的潜在益处和风险。